If you have ever felt confused by cholesterol numbers, you are not alone. The 2026 cholesterol guidelines help patients and providers assess risk in a more personalized way and create treatment plans tailored to each person. They emphasize identifying risk earlier, looking at the full picture of your health, and making sure treatment helps you reach the right goals over time.
What Is Different in the Updated Guidelines?
- Cholesterol care starts earlier. We are recognizing high LDL "bad cholesterol" in young individuals. Guidelines are adjusting for this because we know long-term exposure to high LDL is a major cause of heart disease leading to stroke and heart attacks.
- Risk is more personalized. Providers are encouraged to look beyond basic risk calculators and consider family history and other individual risk factors.
- Cholesterol targets are back. Treatment success is measured by whether cholesterol levels reach appropriate goals, not just by which medication is prescribed.
- Additional testing helps to determine risk in patients. Certain blood tests can clarify risk when standard cholesterol numbers do not tell the full story.
- Imaging can be useful in selected cases. Newer minimally invasive heart scans help identify plaque before symptoms develop, giving providers the opportunity to treat obstructing plaques in a controlled, planned setting instead of an emergent situation.
Additional Testing and Risk Assessment
What Are ApoB and Lp(a)?
In addition to standard cholesterol tests, the guidelines highlight two blood markers that can give a clearer picture of heart disease risk: apolipoprotein B (ApoB) and lipoprotein(a) (Lp(a)).
- ApoB measures how many "bad cholesterol" particles are in your blood. Since each particle has one ApoB, a higher ApoB means more particles that can lead to plaque and heart disease. These particles can enter the walls of your arteries, and over time they contribute to plaque and narrow blood flow.
- Lp(a) is a special type of cholesterol particle that is genetically inherited. It's similar to LDL, but with an extra protein attached that makes it stickier inside blood vessels and more likely to cause inflammation and clotting. Because of this, high Lp(a) is linked to heart attacks, stroke, and aortic valve disease.
What About Newer Heart Scans and Plaque Analysis?
One example of a newer heart scan approach is Cleerly testing. Cleerly is not a separate scan by itself. It is an AI-based analysis of a coronary CT angiography, also called a CCTA, which is a heart scan that looks at the arteries that supply blood to the heart. This test can show how much plaque exists, where it is in the coronary arteries, and the type of plaque (soft vs. calcified). Cleerly gives a more complete picture of coronary artery disease rather than a calcium score alone.
This does not mean everyone needs Cleerly testing or advanced heart imaging. In many cases, regular lab work, blood pressure checks, and a discussion with your provider are enough. But if your risk is still unclear, or if your symptoms, family history, or other test results raise more questions, a CCTA with plaque analysis may sometimes help guide next steps.
A Personalized Approach to Cholesterol
The 2026 cholesterol guidelines place a greater focus on whether your cholesterol is reaching the right range for your personal risk. This means treatment is more than simply taking a cholesterol lowering medication, it's also about making sure the treatment is working as intended to prevent stroke and heart attacks. If you already have heart or blood vessel disease, your provider may recommend a lower LDL cholesterol level and add or adjust treatment if needed. If your LDL is very high, treatment may also need to be more intensive because prolonged exposure to high cholesterol increases your risk over time. If you have never had a heart-related event, your treatment recommendations may instead be based on your overall cardiovascular risk rather than a single cholesterol number.
How Live Well Can Help
If all of this feels like a lot, having the right kind of primary care support can help. Direct primary care is designed to give patients more time, easier access, and more ongoing support. At Live Well DPC, that includes personalized testing and treatment options to help manage cholesterol, blood pressure, and diabetes, and more time to talk through test results and treatment options in a way that feels less rushed.
It can also make follow-up easier. Support with labs, imaging, telemedicine, and urgent questions helps patients stay on track, adjust treatment sooner when needed, and feel more confident about what to do next. Sometimes the biggest benefit is not just getting a test ordered, but having someone help you understand the results and building a plan to prevent chronic disease, keeping you Living Well.
